JP5172708B2 - 耐流出性抗生物質製剤 - Google Patents
耐流出性抗生物質製剤 Download PDFInfo
- Publication number
- JP5172708B2 JP5172708B2 JP2008554281A JP2008554281A JP5172708B2 JP 5172708 B2 JP5172708 B2 JP 5172708B2 JP 2008554281 A JP2008554281 A JP 2008554281A JP 2008554281 A JP2008554281 A JP 2008554281A JP 5172708 B2 JP5172708 B2 JP 5172708B2
- Authority
- JP
- Japan
- Prior art keywords
- antibiotic
- component set
- component
- spill
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
以下の成分を混合しポリエチレン容器内に保存した。
i.アジスロマイシン一水和物100mg/5mL;200mL/5mL
1.82又は3.64グラムのアジスロマイシン一水和物(Taro Pharmaceutical社)を100mlの成分Aに添加し、強く振り混ぜた。0.30mlの水酸化ナトリウム10%溶液を添加して、最終pHにし、製品の耐流出特性を確保した。 このpHは耐流出性製品の化学安定性も保証する。
2.27グラムのエリスロマイシン(Alembic社。インド、グジャラート)を100mlの成分Aに添加して、強く振り混ぜた。0.30mlの水酸化ナトリウムの10%溶液を添加して最終pHにした。このpHは耐流出性製品の化学安定性も保証する。
2.28グラムのクラリスロマイシン(Matrix Laboratories社、インド、セクンデラバード)を100mlの成分Aに添加し、強く振り混ぜた。0.30mlの水酸化ナトリウムの10%溶液を添加して最終pHにした。このpHは耐流出性製品の化学安定性も保証する。
市販のアモキシリン、オウグメンチン及びオムニセフ乾燥製品を用いて上述の手順により、耐流出性バージョンが成功裏に得られた。
Claims (5)
- 第一成分セット、第二成分セット及び第三成分セットを含む医薬品キットであって、前記第一成分セットが、水性ビヒクル中にカルボマーを含み、前記第二成分セットが、抗生物質を含み、前記第三セットが、中和剤を含有し、前記第一、第二及び第三成分セットを一緒に混合すると、pH4.6から7.0でかつ5000から15000cps)の粘度を有する経口投与用の耐流出性組成物を生成することを特徴とするキット。
- 抗生物質が、セファラスポリン、β−ラクタマーゼ阻害剤、モノバクタム、β−ラクタム、キノロン、マクロライド、アミノグリコシド、バンコマイシン、ストレプトグラミン、オキサゾリンジノンの単体又は組み合わせから成る薬物群から選択される、請求項1に記載のキット。
- 抗生物質が、アモキシシリン、セフジニル、アジスロマイシン、エリスロマイシン、クレルスロマイシン、シプロフロキサシン、セファレキシン及びその組み合わせから成る薬物群から選択される、請求項1に記載のキット。
- 第一成分セットが、刻み目のない側面が滑らかなスクイーズ性容器内にある請求項1に記載のキット。
- 第一成分セットが、スクラロース、ソルビトール、カルボマー、グリセリン、プロピレングリコール及びブチルパラベンを含む水性ビヒクルである、請求項1に記載のキット。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76561406P | 2006-02-06 | 2006-02-06 | |
US60/765,614 | 2006-02-06 | ||
PCT/US2007/002910 WO2007092318A2 (en) | 2006-02-06 | 2007-02-02 | Spill resistant antibiotic formulations |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012252187A Division JP2013032401A (ja) | 2006-02-06 | 2012-11-16 | 耐流出性抗生物質製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009526057A JP2009526057A (ja) | 2009-07-16 |
JP5172708B2 true JP5172708B2 (ja) | 2013-03-27 |
Family
ID=38345684
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008554281A Expired - Fee Related JP5172708B2 (ja) | 2006-02-06 | 2007-02-02 | 耐流出性抗生物質製剤 |
JP2012252187A Abandoned JP2013032401A (ja) | 2006-02-06 | 2012-11-16 | 耐流出性抗生物質製剤 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012252187A Abandoned JP2013032401A (ja) | 2006-02-06 | 2012-11-16 | 耐流出性抗生物質製剤 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20090023638A1 (ja) |
EP (1) | EP1981473A4 (ja) |
JP (2) | JP5172708B2 (ja) |
CA (1) | CA2641450A1 (ja) |
WO (1) | WO2007092318A2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100158821A1 (en) * | 2008-12-22 | 2010-06-24 | Eastman Chemical Company | Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
US8106111B2 (en) * | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2194144B (en) * | 1986-08-22 | 1990-04-25 | American Cyanamid Co | Stable pharmaceutical gel preparation |
JPS6251619A (ja) * | 1985-08-30 | 1987-03-06 | Wako Pure Chem Ind Ltd | 外用ゲル製剤 |
TW203552B (en) * | 1992-02-18 | 1993-04-11 | J Baroody Lloyd | Compositions of clindamycin and benzoyl peroxide for acne treatment |
IL108366A (en) * | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
DE19603906A1 (de) * | 1996-02-03 | 1997-08-07 | Wella Ag | Flaschenartiger Behälter aus Kunststoff und Verfahren zu seiner Herstellung |
US6071523A (en) * | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
US7094431B2 (en) * | 2000-10-12 | 2006-08-22 | Mickey L. Peshoff | Method of healing skin wounds in mammals and a composition therefor |
KR20040088022A (ko) * | 2001-10-22 | 2004-10-15 | 타로 파르마수티컬 인더스트리즈, 엘티디. | 내유출성 제제를 분배하기 위한 용기 |
WO2003063999A1 (en) * | 2002-01-31 | 2003-08-07 | Tillin, Inc. | Methods of treating commercial grade preservatives to remove undesirable odors and flavors |
CN101862292A (zh) * | 2002-06-17 | 2010-10-20 | 塔罗制药美国公司 | 布洛芬混悬剂 |
-
2007
- 2007-02-02 WO PCT/US2007/002910 patent/WO2007092318A2/en active Application Filing
- 2007-02-02 JP JP2008554281A patent/JP5172708B2/ja not_active Expired - Fee Related
- 2007-02-02 CA CA002641450A patent/CA2641450A1/en not_active Abandoned
- 2007-02-02 EP EP07717182A patent/EP1981473A4/en not_active Withdrawn
- 2007-02-02 US US12/162,675 patent/US20090023638A1/en not_active Abandoned
-
2012
- 2012-11-16 JP JP2012252187A patent/JP2013032401A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090023638A1 (en) | 2009-01-22 |
CA2641450A1 (en) | 2007-08-16 |
EP1981473A2 (en) | 2008-10-22 |
EP1981473A4 (en) | 2012-12-26 |
JP2013032401A (ja) | 2013-02-14 |
JP2009526057A (ja) | 2009-07-16 |
WO2007092318A3 (en) | 2007-11-01 |
WO2007092318A2 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7981435B2 (en) | Spill resistant formulations containing clays | |
AU2015305510B2 (en) | Natural suspending agent including a synergistic blend of Xanthan gum and Konjac powder for oral pharmaceutical suspensions | |
EP1513499B1 (en) | Ibuprofen suspension | |
US20120129951A1 (en) | Palatable Suspending Vehicle for Pharmaceutical Ingredients | |
US20100261748A1 (en) | Stable loratadine spill resistant formulation | |
JP2013139467A (ja) | 親水コロイド重合体を含む新規な耐流出性製剤 | |
Bravo-José et al. | Combining liquid oral drugs with thickener: compatibility and changes in viscosity | |
JP5172708B2 (ja) | 耐流出性抗生物質製剤 | |
US20030235618A1 (en) | Taste masking spill-resistant formulation | |
US8999395B2 (en) | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions | |
US20050143471A1 (en) | Taste masking spill-resistant formulation | |
CN110604819A (zh) | 控制释放组合物及其使用方法 | |
Gupta et al. | Pharmaceutical Suspension: A review | |
Remya et al. | Development and Evaluation of Floating in-Situ Gel Solution of Lansoprazole | |
Kovačević et al. | Veterinary compounding: the impact of different gelling agents on the rheological characteristics and release kinetics from meloxicam oral gels in the treatment of cats | |
AU2015261543C1 (en) | Controlled release compositions and their methods of use | |
JPH11322606A (ja) | 易嚥下性抗悪性腫瘍製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120717 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120719 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121016 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121023 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121116 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121217 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121226 |
|
LAPS | Cancellation because of no payment of annual fees |